Yi-Ming Zhu

Yi-Ming Zhu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Translational Oncology
Verified
Journal Article
Open access
CZChihao Zhang
Chihao Zhang
RZRan Zhao
Ran Zhao
FCFancheng Chen
Fancheng Chen
YZYi-Ming Zhu
Yi-Ming Zhu
LCLiubo Chen
Liubo Chen
The presence of microvascular invasion (MVI) is an unfavorable prognostic factor for hepatocellular carcinoma (HCC). This study aimed to construct a nomogram-based preoperative prediction model of MVI, thereby assisting to preoperatively select proper surgical procedures. A total of 714 non-metastatic HCC patients undergoing radical hepatectomy were retrospectively selected from Zhongshan Hospital between 2010 and 2018, followed by random assignment into training (N = 520) and validation cohorts (N = 194). Nomogram-based prediction model for MVI risk was constructed by incorporating independent risk factors of MVI presence identified from multivariate backward logistic regression analysis in the training cohort. The performance of nomogram was evaluated by calibration curve and ROC curve. Finally, decision curve analysis (DCA) was used to determine the clinical utility of the nomogram. In total, 503 (70.4%) patients presented MVI. Multivariate analysis in the training cohort revealed that age (OR: 0.98), alpha-fetoprotein (≥400 ng/mL) (OR: 2.34), tumor size (>5 cm) (OR: 3.15), cirrhosis (OR: 2.03) and γ-glutamyl transpeptidase (OR: 1.61) were significantly associated with MVI presence. The incorporation of five risk factors into a nomogram-based preoperative estimation of MVI risk demonstrated satisfactory discriminative capacity, with C-index of 0.702 and 0.690 in training and validation cohorts, respectively. Calibration curve showed good agreement between actual and predicted MVI risks. Finally, DCA revealed the clinical utility of the nomogram. The nomogram showed a satisfactory discriminative capacity of MVI risk in HCC patients, and could be used to preoperatively estimate MVI risk, thereby establishing more rational therapeutic strategies.

1 January 2019 in Journal of Cancer
Verified
Journal Article
Open access
CZChi-Hao Zhang
Chi-Hao Zhang
XNXiao-Chun Ni
Xiao-Chun Ni
BCBi-Yin Chen
Bi-Yin Chen
SQShuang-Jian Qiu
Shuang-Jian Qiu
YZYi-Ming Zhu
Yi-Ming Zhu
MLMeng Luo
Meng Luo
Background: Liver function is an important prognostic factor for patients with hepatocellular carcinoma. The purpose of this study was to develop and validate a nomogram integrating the albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) level to predict postoperative overall survival (OS) and disease-free survival (DFS) of hepatocellular carcinoma (HCC).

28 November 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YSYe‐Min Shi
Ye‐Min Shi
YLYan‐Yan Li
Yan‐Yan Li
JLJia‐Yun Lin
Jia‐Yun Lin
LZLei Zheng
Lei Zheng
YZYi-Ming Zhu
Yi-Ming Zhu
JHJian Huang
Jian Huang